S. M. Konev, E. S. Koneva, A. S. Mochalova, E. N. Zhumanova, M. S. Suetina
{"title":"扩展研究:在接受免疫治疗的黑色素瘤患者中使用康复磁疗的经验","authors":"S. M. Konev, E. S. Koneva, A. S. Mochalova, E. N. Zhumanova, M. S. Suetina","doi":"10.33920/med-14-2305-08","DOIUrl":null,"url":null,"abstract":"Immunotherapy is becoming an increasingly popular cancer treatment method due to its high specificity and potential to be more effective than traditional approaches. The problem of the use of concomitant rehabilitation measures remains in the highlight, as they can help reduce unwanted side effects of the main treatment and improve the overall quality of life of patients. Purpose of the study. To expand the comparative analysis of the quality of life of patients diagnosed with melanoma and receiving immunotherapy, as well as the overall response rate during treatment with the use of accompanying rehabilitation magnetotherapy. Materials and methods. The study included 128 patients diagnosed with melanoma and receiving immunotherapy with pembrolizumab or nivolumab. The patients of the study group (n = 67) underwent a course of immunotherapy and an accompanying course of rehabilitation magnetotherapy. The patients in the control group underwent a course of immunotherapy without accompanying rehabilitation magnetotherapy. Treatment efficacy was assessed according to iRECIST 1.1 criteria. The EORTC QLQ-C30 questionnaire was used to study the quality of life. The degree of adverse events was assessed according to CTCAE 5.0 criteria. Results. The objective response rate in the study group (70.1 %) was higher than in the control group (65.6 %). Stabilization was the most frequent response to systemic treatment in most cases: 41.8 % in the study group and 49.2 % in the control group. In the study group, the improvement in the overall quality of life was more noticeable and amounted to 9.6 %, while in the control group, the improvement was at the level of 6.2 % (Т = 0.4, р = 0.023). Improvement in the general level of health was noted by 10.9 % in the study group and by 5.4 % in the control group (Т = 0.43, р = 0.015). Conclusion. The use of accompanying rehabilitation magnetotherapy during the course of immunotherapy led to an improvement in the overall quality of life of patients and a decrease in treatment side effects. Further research in this area is needed in order to determine the potential of magnetotherapy as an additional rehabilitation method.","PeriodicalId":493919,"journal":{"name":"Физиотерапевт","volume":"125 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Extended study: experience of using rehabilitation magnetotherapy in patients with melanoma receiving immunotherapy\",\"authors\":\"S. M. Konev, E. S. Koneva, A. S. Mochalova, E. N. Zhumanova, M. S. Suetina\",\"doi\":\"10.33920/med-14-2305-08\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immunotherapy is becoming an increasingly popular cancer treatment method due to its high specificity and potential to be more effective than traditional approaches. The problem of the use of concomitant rehabilitation measures remains in the highlight, as they can help reduce unwanted side effects of the main treatment and improve the overall quality of life of patients. Purpose of the study. To expand the comparative analysis of the quality of life of patients diagnosed with melanoma and receiving immunotherapy, as well as the overall response rate during treatment with the use of accompanying rehabilitation magnetotherapy. Materials and methods. The study included 128 patients diagnosed with melanoma and receiving immunotherapy with pembrolizumab or nivolumab. The patients of the study group (n = 67) underwent a course of immunotherapy and an accompanying course of rehabilitation magnetotherapy. The patients in the control group underwent a course of immunotherapy without accompanying rehabilitation magnetotherapy. Treatment efficacy was assessed according to iRECIST 1.1 criteria. The EORTC QLQ-C30 questionnaire was used to study the quality of life. The degree of adverse events was assessed according to CTCAE 5.0 criteria. Results. The objective response rate in the study group (70.1 %) was higher than in the control group (65.6 %). Stabilization was the most frequent response to systemic treatment in most cases: 41.8 % in the study group and 49.2 % in the control group. In the study group, the improvement in the overall quality of life was more noticeable and amounted to 9.6 %, while in the control group, the improvement was at the level of 6.2 % (Т = 0.4, р = 0.023). Improvement in the general level of health was noted by 10.9 % in the study group and by 5.4 % in the control group (Т = 0.43, р = 0.015). Conclusion. The use of accompanying rehabilitation magnetotherapy during the course of immunotherapy led to an improvement in the overall quality of life of patients and a decrease in treatment side effects. Further research in this area is needed in order to determine the potential of magnetotherapy as an additional rehabilitation method.\",\"PeriodicalId\":493919,\"journal\":{\"name\":\"Физиотерапевт\",\"volume\":\"125 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Физиотерапевт\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33920/med-14-2305-08\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Физиотерапевт","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33920/med-14-2305-08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
免疫治疗由于其高特异性和比传统方法更有效的潜力而成为越来越受欢迎的癌症治疗方法。使用伴随康复措施的问题仍然是重点,因为它们可以帮助减少主要治疗的不良副作用,提高患者的整体生活质量。研究目的:扩大对诊断为黑色素瘤并接受免疫治疗的患者的生活质量及伴随康复磁疗治疗期间的总有效率的对比分析。材料和方法。该研究包括128名诊断为黑色素瘤并接受派姆单抗或纳武单抗免疫治疗的患者。研究组患者(67例)接受1个疗程的免疫治疗和1个疗程的康复磁疗。对照组患者接受一个疗程的免疫治疗,不伴有康复磁疗。按照iRECIST 1.1标准评价治疗效果。采用EORTC QLQ-C30问卷对生活质量进行研究。不良事件程度按CTCAE 5.0标准评定。结果。研究组客观有效率(70.1%)高于对照组(65.6%)。在大多数情况下,稳定是对全身治疗最常见的反应:研究组为41.8%,对照组为49.2%。研究组整体生活质量的改善更为明显,达9.6%,而对照组的改善水平为6.2% (Т = 0.4, r = 0.023)。研究组的总体健康水平提高了10.9%,对照组提高了5.4% (Т = 0.43, r = 0.015)。结论。在免疫治疗过程中使用伴随的康复磁疗导致患者整体生活质量的改善和治疗副作用的减少。为了确定磁疗作为一种额外康复方法的潜力,需要在这一领域进行进一步的研究。
Extended study: experience of using rehabilitation magnetotherapy in patients with melanoma receiving immunotherapy
Immunotherapy is becoming an increasingly popular cancer treatment method due to its high specificity and potential to be more effective than traditional approaches. The problem of the use of concomitant rehabilitation measures remains in the highlight, as they can help reduce unwanted side effects of the main treatment and improve the overall quality of life of patients. Purpose of the study. To expand the comparative analysis of the quality of life of patients diagnosed with melanoma and receiving immunotherapy, as well as the overall response rate during treatment with the use of accompanying rehabilitation magnetotherapy. Materials and methods. The study included 128 patients diagnosed with melanoma and receiving immunotherapy with pembrolizumab or nivolumab. The patients of the study group (n = 67) underwent a course of immunotherapy and an accompanying course of rehabilitation magnetotherapy. The patients in the control group underwent a course of immunotherapy without accompanying rehabilitation magnetotherapy. Treatment efficacy was assessed according to iRECIST 1.1 criteria. The EORTC QLQ-C30 questionnaire was used to study the quality of life. The degree of adverse events was assessed according to CTCAE 5.0 criteria. Results. The objective response rate in the study group (70.1 %) was higher than in the control group (65.6 %). Stabilization was the most frequent response to systemic treatment in most cases: 41.8 % in the study group and 49.2 % in the control group. In the study group, the improvement in the overall quality of life was more noticeable and amounted to 9.6 %, while in the control group, the improvement was at the level of 6.2 % (Т = 0.4, р = 0.023). Improvement in the general level of health was noted by 10.9 % in the study group and by 5.4 % in the control group (Т = 0.43, р = 0.015). Conclusion. The use of accompanying rehabilitation magnetotherapy during the course of immunotherapy led to an improvement in the overall quality of life of patients and a decrease in treatment side effects. Further research in this area is needed in order to determine the potential of magnetotherapy as an additional rehabilitation method.